|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siewert JR, Böttcher K, Stein HJ and Roder
JD: Relevant prognostic factors in gastric cancer: Ten-year results
of the German Gastric Cancer Study. Ann Surg. 228:449–461. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inoue K, Nakane Y, Iiyama H, Sato M,
Kanbara T, Nakai K, Okumura S, Yamamichi K and Hioki K: The
superiority of ratio-based lymph node staging in gastric carcinoma.
Ann Surg Oncol. 9:27–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nitti D, Marchet A, Olivieri M, Ambrosi A,
Mencarelli R, Belluco C and Lise M: Ratio between metastatic and
examined lymph nodes is an independent prognostic factor after D2
resection for gastric cancer: Analysis of a large European
monoinstitutional experience. Ann Surg Oncol. 10:1077–1085. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Dang P, Raut CP, Pandalai PK,
Maduekwe UN, Rattner DW, Lauwers GY and Yoon SS: Comparison of a
lymph node ratio-based staging system with the 7th AJCC system for
gastric cancer: Analysis of 18,043 patients from the SEER database.
Ann Surg. 255:478–485. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu XJ, Miao RL, Li ZY, Bu ZD, Zhang LH, Wu
AW, Zong XL, Li SX, Shan F, Ji X, et al: Prognostic value of
metastatic lymph node ratio as an additional tool to the TNM stage
system in gastric cancer. Eur J Surg Oncol. 41:927–933. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD,
Zhao HL, Peng CW, Yang GF and Li Y: Lymph node ratio is a better
prognosticator than lymph node status for gastric cancer: A
retrospective study of 138 cases. Oncol Lett. 6:1693–1700. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dikken JL, van de Velde CJ, Gönen M,
Verheij M, Brennan MF and Coit DG: The New American Joint Committee
on Cancer/International Union Against Cancer staging system for
adenocarcinoma of the stomach: Increased complexity without clear
improvement in predictive accuracy. Ann Surg Oncol. 19:2443–2451.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH and
Lu YY: Evaluation of the prognostic value of the metastatic lymph
node ratio for gastric cancer. Am J Surg. 207:555–565. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng J, Zhang R, Wu L, Zhang L, Wang X,
Liu Y, Hao X and Liang H: Superiority of the ratio between negative
and positive lymph nodes for predicting the prognosis for patients
with gastric cancer. Ann Surg Oncol. 22:1258–1266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao LY, Li CC, Jia LY, Chen XL, Zhang WH,
Chen XZ, Yang K, Liu K, Wang YG, Xue L, et al: Superiority of lymph
node ratio-based staging system for prognostic prediction in 2575
patients with gastric cancer: Validation analysis in a large single
center. Oncotarget. 7:51069–51081. 2016.PubMed/NCBI
|
|
14
|
Espín F, Bianchi A, Llorca S, Feliu J,
Palomera E, García O, Remon J and Suñol X: Metastatic lymph node
ratio versus number of metastatic lymph nodes as a prognostic
factor in gastric cancer. Eur J Surg Oncol. 38:497–502. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamashita K, Sakuramoto S, Katada N,
Futawatari N, Moriya H, Hirai K, Kikuchi S and Watanabe M: Diffuse
type advanced gastric cancer showing dismal prognosis is
characterized by deeper invasion and emerging peritoneal cancer
cell: The latest comparative study to intestinal advanced gastric
cancer. Hepatogastroenterology. 56:276–281. 2009.PubMed/NCBI
|
|
16
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological
characteristics of intestinal and diffuse-type gastric carcinoma in
Japan: An immunostaining study on the tissue microarray. J Clin
Pathol. 60:273–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen YC, Fang WL, Wang RF, Liu CA, Yang
MH, Lo SS, Wu CW, Li AF, Shyr YM and Huang KH: Clinicopathological
variation of lauren classification in gastric cancer. Pathol Oncol
Res. 22:197–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SR, Kim HO, Son BH, Shin JH and Yoo
CH: Prognostic significance of the metastatic lymph node ratio in
patients with gastric cancer. World J Surg. 36:1096–1101. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Riediger H, Keck T, Wellner U, zur Hausen
A, Adam U, Hopt UT and Makowiec F: The lymph node ratio is the
strongest prognostic factor after resection of pancreatic cancer. J
Gastrointest Surg. 13:1337–1344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Lv L, Ye Y, Jiang K, Shen Z and
Wang S: Comparison of metastatic lymph node ratio staging system
with the 7th AJCC system for colorectal cancer. J Cancer Res Clin
Oncol. 139:1947–1953. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wilson M, Rosato EL, Chojnacki KA,
Chervoneva I, Kairys JC, Cohn HE, Rosato FE Sr and Berger AC:
Prognostic significance of lymph node metastases and ratio in
esophageal cancer. J Surg Res. 146:11–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SY, Hwang I, Park YS, Gardner J and Ro
JY: Metastatic lymph node ratio in advanced gastric carcinoma: A
better prognostic factor than number of metastatic lymph nodes? Int
J Oncol. 36:1461–1467. 2010.PubMed/NCBI
|
|
24
|
Liu YP, Ma L, Wang SJ, Chen YN, Wu GX, Han
M and Wang XL: Prognostic value of lymph node metastases and lymph
node ratio in esophageal squamous cell carcinoma. Eur J Surg Oncol.
36:155–159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li
K, Xu Y, Li DM, Wang ZN and Xu HM: The impact of N-ratio in
minimizing stage migration phenomenon in gastric cancer patients
with insufficient number or level of lymph node retrieved: Results
from a Chinese mono-institutional study in 2159 patients. Ann
Oncol. 20:897–905. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wong J, Rahman S, Saeed N, Lin HY,
Almhanna K, Shridhar R, Hoffe S and Meredith KL: Prognostic impact
of lymph node retrieval and ratio in gastric cancer: A U.S. single
center experience. J Gastrointest Surg. 17:2059–2066. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bando E, Yonemura Y, Taniguchi K, Fushida
S, Fujimura T and Miwa K: Outcome of ratio of lymph node metastasis
in gastric carcinoma. Ann Surg Oncol. 9:775–784. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dings PJ, Elferink MA, Strobbe LJ and de
Wilt JH: The prognostic value of lymph node ratio in node-positive
breast cancer: A Dutch nationwide population-based study. Ann Surg
Oncol. 20:2607–2614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Taat CW, van Laschot JJ, Gouma DJ and
Obertop H: Role of extended lymph node dissection in the treatment
of gastrointestinal tumours: A review of the literature. Scand J
Gastroenterol Suppl. 212:109–116. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McCulloch P, Nita ME, Kazi H and
Gama-Rodrigues J: Extended versus limited lymph nodes dissection
technique for adenocarcinoma of the stomach. Cochrane Database Syst
Rev: CD001964. 2004.
|
|
31
|
Huang J, Hu W, Pang L, Chen J and Yang H:
Value of positive lymph node ratio for predicting postoperative
distant metastasis and prognosis in esophageal squamous cell
carcinoma. Oncol Res Treat. 38:424–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang YJ, Chung KP, Chen LJ and Chang YJ:
Recursive partitioning analysis of lymph node ratio in breast
cancer patients. Medicine (Baltimore). 94:e2082015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun G, Xue L, Wang M and Zhao X: Lymph
node ratio is a prognostic factor for non-small cell lung cancer.
Oncotarget. 6:33912–33918. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mirzaei Zare A, Abdorrazaghi F, Lotfi M,
Nejad Kazemi B and Shayanfar N: Prognostic value of lymph node
ratio in comparison to lymph node metastases in stage III colon
cancer. Iran J Pathol. 10:127–135. 2015.PubMed/NCBI
|
|
35
|
Zhan HX, Xu JW, Wang L, Zhang GY and Hu
SY: Lymph node ratio is an independent prognostic factor for
patients after resection of pancreatic cancer. World J Surg Oncol.
13:1052015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Flatow V, Warner RR, Overbey J and Divino
CM: The prognostic significance of lymph node ratio in carcinoid
tumors. Pancreas. 45:342–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi JK, Park YS, Jung DH, Son SY, Ahn SH,
Park DJ and Kim HH: Clinical relevance of the tumor
location-modified lauren classification system of gastric cancer. J
Gastric Cancer. 15:183–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qiu MZ, Cai MY, Zhang DS, Wang ZQ, Wang
DS, Li YH and Xu RH: Clinicopathological characteristics and
prognostic analysis of Lauren classification in gastric
adenocarcinoma in China. J Transl Med. 11:582013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Berlth F, Bollschweiler E, Drebber U,
Hoelscher AH and Moenig S: Pathohistological classification systems
in gastric cancer: Diagnostic relevance and prognostic value. World
J Gastroenterol. 20:5679–5684. 2014. View Article : Google Scholar : PubMed/NCBI
|
